SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-24-000052
Filing Date
2024-04-18
Accepted
2024-04-18 16:53:11
Documents
16
Period of Report
2024-04-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20240418.htm   iXBRL 8-K 25087
2 EX-99.1 lumo-20240418x8kxex991.htm EX-99.1 23449
7 image_1.jpg GRAPHIC 7147
  Complete submission text file 0001126234-24-000052.txt   220705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20240418.xsd EX-101.SCH 2252
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20240418_def.xml EX-101.DEF 14926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20240418_lab.xml EX-101.LAB 26322
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20240418_pre.xml EX-101.PRE 15561
19 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20240418_htm.xml XML 2786
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 24854872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)